Garry Michael Kann
Corporate Officer/Principal chez ENDONOVO THERAPEUTICS, INC.
Profil
Garry Michael Kann is currently the Head of Corporate Development at Endonovo Therapeutics, Inc. and a Partner at The Firebird Partnership Ltd.
He obtained an undergraduate degree from Kean University.
Postes actifs de Garry Michael Kann
| Sociétés | Poste | Début |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2022 |
The Firebird Partnership Ltd.
 The Firebird Partnership Ltd. Financial ConglomeratesFinance The Firebird Partnership Ltd. provides investment services. The private company is based in Winchester, UK. The British company was founded in 2020 by Stewart Alexander Lambert, Ian Stuart Finlay. | Corporate Officer/Principal | - |
Formation de Garry Michael Kann
| Kean University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENDONOVO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
The Firebird Partnership Ltd.
The Firebird Partnership Ltd. Financial ConglomeratesFinance The Firebird Partnership Ltd. provides investment services. The private company is based in Winchester, UK. The British company was founded in 2020 by Stewart Alexander Lambert, Ian Stuart Finlay. | Finance |